2018
Mumbai (India)
Seed
AADAR is a digital-first Ayurveda wellness brand focused on providing science-backed, easy-to-consume health solutions, with a particular emphasis on men’s wellness and sexual health. The company leverages ancient Ayurvedic wisdom, integrating it with modern technology to address contemporary health and lifestyle needs. Its platform offers a safe, judgment-free space for open discussion of sensitive health topics, which is a key differentiator in the Indian wellness market.
Men’s Wellness: Performance capsules, oils and supplements for sexual health, stamina, and energy (e.g., Safed Musli, Ashwagandha, Shilajit blends).
Women’s Health: Products for hormone balance, PCOS/PCOD support and menstrual wellness (e.g., Good Period capsules, pain relief roll-ons).
General Wellness: Solutions for digestion, diabetes management, immunity, joint health and detoxification (e.g., Jeevani capsules, Ortho Sure pain relief, ReLAX digestive wellness).
Digital Platform: A safe, interactive space for health education, community engagement and personalized wellness guidance.
Revenue Streams: The majority of revenue comes from e-commerce sales of proprietary Ayurvedic products, with additional income from partnerships and select offline channels.
Revenue Mix: As of 2024, over 90% of revenue is attributed to online sales, with men’s wellness products representing the largest share, followed by women’s health and general wellness categories.
Customer Segmentation: AADAR serves a predominantly B2C customer base, targeting urban and semi-urban millennials and Gen Z consumers, but also reaches B2B partners through collaborations with digital health platforms and retail aggregators.
E-commerce Partners: Amazon, Flipkart, 1mg, Pharmeasy, Netmeds and other leading online health marketplaces drive the bulk of product distribution and sales.
Strategic Investors: Backed by Sprout Venture Partners, LetsVenture and JITO Angel Network, providing both capital and industry expertise.
Advisory Board: Includes industry veterans such as Syed Safawi (ex-VLCC MD), supporting product and market strategy.
Client Concentration Risk: The company’s diversified online presence and multi-category product portfolio mitigate reliance on any single channel or customer group, supporting sustainable growth and reducing concentration risk.
Growth Drivers: Launch of new daily supplements, expansion into women’s wellness and general health categories, and deeper penetration into Tier 2/3 cities via digital channels (reflecting recent market trends toward holistic, preventive healthcare).
Risks & Headwinds: Regulatory scrutiny of health claims, intensifying competition in the Ayurveda and wellness space, and the need for ongoing consumer education on product efficacy.
Management Targets & Capital Allocation: The company aims to achieve ₹100 crore ($13.9 million) in annual revenue by 2026, with capital directed toward R&D, digital marketing, and expanding its product portfolio. Strategic priorities include scaling the D2C platform, enhancing supply chain efficiency and forging new partnerships to accelerate growth.
$744K
5
$83.0K, Angel
as of July 5, 2022
$1.2Million
as of N/A
-
as of N/A
LetsVenture
and 4 more43
Orange health
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
July 5, 2022 | Angel | $83.0K | $1.2Million | $171.0K | 6.7x | - |
September 17, 2021 | Seed | $177.0K | $1.2Million | $194.0K | 5.2x | Artha Venture Fund, Sprout Venture Partners |
January 10, 2020 | Seed | $250.0K | - | $60.9K | - | Sprout Venture Partners, JITO Incubation & Innovation Foundation , LetsVenture |
May 6, 2019 | Seed | $221.0K | $601.0K | $20.6K | 18.5x | Sprout Venture Partners, Elina Investments LetsVenture, Urban Land Layout Promoters, Singhvi Heritage |
January 29, 2019 | Angel | $13.4K | $546.0K | - | - | - |